The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world. In addition, this edition includes the recommendations from the Pharmacovigilance Meeting of the Members of the WHO Programme for International Drug Monitoring (PIDM) and Partners in Africa, March 2023.

The Product Design and Impact Unit of the Department of Quality Assurance, Norms and Standards, in collaboration with the Monash University’s Design Health Collab, conducted a hybrid co-design workshop in Geneva and online on 7 September 2022. The objective of this ongoing collaboration is to understand how WHO guidelines can be planned and developed to improve their usability and impact. The aim of this event, the second in a series of co-design workshops, was to evaluate the prototype design principles that are part of the Design toolkit for WHO guideline developers: principles and tools. The principles were developed on the basis of insights shared in the first workshop, held on 7 April 2022, and reported in Improving the usability and impact of WHO guidelines: report of a WHO workshop.